| scholarly article | Q13442814 |
| P2093 | author name string | José A Melero | |
| Martin L Moore | |||
| P2860 | cites work | Adaptation of Respiratory Syncytial (RS) Virus to Brain of Suckling Mice | Q45812242 |
| Repeated infections with respiratory syncytial virus | Q45824459 | ||
| Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells | Q45831157 | ||
| Antigenic characterization of respiratory syncytial virus strains with monoclonal antibodies | Q45844409 | ||
| Two distinct subtypes of human respiratory syncytial virus | Q45848624 | ||
| Occurrence of groups A and B of respiratory syncytial virus over 15 years: associated epidemiologic and clinical characteristics in hospitalized and ambulatory children | Q45850046 | ||
| Group-specific serum antibody responses in children with primary and recurrent respiratory syncytial virus infections | Q45852624 | ||
| Immunity to and frequency of reinfection with respiratory syncytial virus | Q45853042 | ||
| Humoral immunity to respiratory syncytial virus infection in the elderly | Q45866710 | ||
| A phylogenetic study of human respiratory syncytial viruses group A and B strains isolated in two cities in Japan from 1980-2002. | Q47813174 | ||
| Respiratory syncytial viral infection in children with compromised immune function | Q69554112 | ||
| A single mutation in the PB1-F2 of H5N1 (HK/97) and 1918 influenza A viruses contributes to increased virulence | Q21089626 | ||
| Neutralization epitopes of the F glycoprotein of respiratory syncytial virus: effect of mutation upon fusion function | Q27486621 | ||
| Characterization of the reconstructed 1918 Spanish influenza pandemic virus | Q28275911 | ||
| Positive Darwinian evolution in human influenza A viruses | Q28775815 | ||
| Characterization of two antigenic sites recognized by neutralizing monoclonal antibodies directed against the fusion glycoprotein of human respiratory syncytial virus | Q30334543 | ||
| In vitro modeling of respiratory syncytial virus infection of pediatric bronchial epithelium, the primary target of infection in vivo | Q30512964 | ||
| Respiratory syncytial virus disease mechanisms implicated by human, animal model, and in vitro data facilitate vaccine strategies and new therapeutics | Q31047884 | ||
| Positive selection results in frequent reversible amino acid replacements in the G protein gene of human respiratory syncytial virus. | Q33396977 | ||
| Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice | Q33558356 | ||
| Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant | Q33738521 | ||
| Identification of and human serum reactogenicity to neutralizing epitopes within the central unglycosylated region of the respiratory syncytial virus attachment protein | Q33768769 | ||
| Genetic variability of respiratory syncytial viruses (RSV) prevalent in Southwestern China from 2006 to 2009: emergence of subgroup B and A RSV as dominant strains | Q33769665 | ||
| Molecular epidemiology and evolution of human respiratory syncytial virus and human metapneumovirus | Q33842098 | ||
| Human respiratory syncytial virus glycoprotein G expressed from a recombinant vaccinia virus vector protects mice against live-virus challenge | Q33928414 | ||
| Multiplex assay for detection of strain-specific antibodies against the two variable regions of the G protein of respiratory syncytial virus | Q33943306 | ||
| Humoral response to the central unglycosylated region of the respiratory syncytial virus attachment protein | Q34069182 | ||
| Risk of primary infection and reinfection with respiratory syncytial virus | Q34188122 | ||
| Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice | Q34199969 | ||
| Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine | Q34206177 | ||
| Lack of antibody affinity maturation due to poor Toll-like receptor stimulation leads to enhanced respiratory syncytial virus disease | Q34330690 | ||
| The G glycoprotein of human respiratory syncytial viruses of subgroups A and B: extensive sequence divergence between antigenically related proteins | Q34337480 | ||
| Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children. The Respiratory Syncytial Virus Immune Globulin Study Group | Q34358628 | ||
| Human Respiratory Syncytial Virus in Children with Acute Respiratory Tract Infections in China | Q34489610 | ||
| Differential pathogenesis of respiratory syncytial virus clinical isolates in BALB/c mice | Q35076998 | ||
| Differential immune responses and pulmonary pathophysiology are induced by two different strains of respiratory syncytial virus | Q35222083 | ||
| A study of the genetic variability of human respiratory syncytial virus (HRSV) in Cambodia reveals the existence of a new HRSV group B genotype | Q35273655 | ||
| Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention | Q35778982 | ||
| The pathogenesis of respiratory syncytial virus infection in infant ferrets | Q36077790 | ||
| Genetic relatedness of infecting and reinfecting respiratory syncytial virus strains identified in a birth cohort from rural Kenya | Q36330977 | ||
| CD8+ T cell responses in bronchoalveolar lavage fluid and peripheral blood mononuclear cells of infants with severe primary respiratory syncytial virus infections | Q45398870 | ||
| Distinct patterns of evolution between respiratory syncytial virus subgroups A and B from New Zealand isolates collected over thirty-seven years. | Q45413095 | ||
| Distribution and clinical impact of human respiratory syncytial virus genotypes in hospitalized children over 2 winter seasons | Q45422006 | ||
| Molecular epidemiology of human respiratory syncytial virus subgroup A over a six-year period (1999-2004) in Argentina | Q45424431 | ||
| Comparison of antibodies directed against human respiratory syncytial virus antigens present in two commercial preparations of human immunoglobulins with different neutralizing activities | Q45553189 | ||
| Variable resistance to palivizumab in cotton rats by respiratory syncytial virus mutants | Q45553883 | ||
| Molecular epidemiology of respiratory syncytial virus in Kilifi district, Kenya | Q45595942 | ||
| Correlation between respiratory syncytial virus genotype and severity of illness | Q45731193 | ||
| Genetic diversity and molecular epidemiology of respiratory syncytial virus over four consecutive seasons in South Africa: identification of new subgroup A and B genotypes | Q45736012 | ||
| Variable immune-driven natural selection in the attachment (G) glycoprotein of respiratory syncytial virus (RSV). | Q45738368 | ||
| Circulation patterns of group A and B human respiratory syncytial virus genotypes in 5 communities in North America | Q45742139 | ||
| Evaluation of the antibody specificities of human convalescent-phase sera against the attachment (G) protein of human respiratory syncytial virus: influence of strain variation and carbohydrate side chains | Q45744225 | ||
| Molecular characterization of a nosocomial outbreak of human respiratory syncytial virus on an adult leukemia/lymphoma ward | Q45746863 | ||
| Prophylaxis with respiratory syncytial virus F-specific humanized monoclonal antibody delays and moderately suppresses the native antibody response but does not impair immunity to late rechallenge | Q45747972 | ||
| Circulation patterns of genetically distinct group A and B strains of human respiratory syncytial virus in a community | Q45753705 | ||
| Enhanced neutralization of human respiratory syncytial virus by mixtures of monoclonal antibodies to the attachment (G) glycoprotein | Q45753707 | ||
| Monoclonal antibody neutralization escape mutants of respiratory syncytial virus with unique alterations in the attachment (G) protein | Q45757184 | ||
| Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults | Q45757918 | ||
| The guinea pig as a model for the study of maternal immunization against respiratory syncytial virus infections in infancy | Q45764053 | ||
| Analysis of the human serological immune response to a variable region of the attachment (G) protein of respiratory syncytial virus during primary infection. | Q45768335 | ||
| The three C-terminal residues of human respiratory syncytial virus G glycoprotein (Long strain) are essential for integrity of multiple epitopes distinguishable by antiidiotypic antibodies | Q45772374 | ||
| Monoclonal antibodies protect against respiratory syncytial virus infection in mice | Q45804443 | ||
| Respiratory syncytial virus infection and its serologic epidemiology | Q45809561 | ||
| A role for immune complexes in enhanced respiratory syncytial virus disease | Q36371267 | ||
| Variation and infectivity neutralization in influenza | Q36573936 | ||
| Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived | Q36683018 | ||
| Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by ant | Q36691093 | ||
| Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins | Q36780922 | ||
| Passive transfer of respiratory syncytial virus (RSV) antiserum suppresses the immune response to the RSV fusion (F) and large (G) glycoproteins expressed by recombinant vaccinia viruses | Q36873249 | ||
| Expression of the fusion protein of human respiratory syncytial virus from recombinant vaccinia virus vectors and protection of vaccinated mice | Q36884312 | ||
| Quantitative aspects of passive immunity to respiratory syncytial virus infection in infant cotton rats | Q36903965 | ||
| Antigenic relatedness between glycoproteins of human respiratory syncytial virus subgroups A and B: evaluation of the contributions of F and G glycoproteins to immunity | Q36919232 | ||
| Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. | Q36920250 | ||
| Mechanisms of immunity to respiratory syncytial virus in cotton rats | Q37103582 | ||
| A chimeric A2 strain of respiratory syncytial virus (RSV) with the fusion protein of RSV strain line 19 exhibits enhanced viral load, mucus, and airway dysfunction | Q37157161 | ||
| Emerging genotypes of human respiratory syncytial virus subgroup A among patients in Japan | Q37302161 | ||
| Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity | Q37401975 | ||
| Immunoprophylaxis of infections with respiratory syncytial virus: observations and hypothesis. | Q37937681 | ||
| Molecular epidemiology of outbreak of respiratory syncytial virus within bone marrow transplantation unit | Q39463548 | ||
| Antigenic structure of human respiratory syncytial virus fusion glycoprotein. | Q39579940 | ||
| Neutralization of human respiratory syncytial virus infectivity by antibodies and low-molecular-weight compounds targeted against the fusion glycoprotein. | Q39695161 | ||
| Natural history of human respiratory syncytial virus inferred from phylogenetic analysis of the attachment (G) glycoprotein with a 60-nucleotide duplication | Q39740579 | ||
| Potent high-affinity antibodies for treatment and prophylaxis of respiratory syncytial virus derived from B cells of infected patients. | Q39785722 | ||
| Evolution of subgroup A respiratory syncytial virus: evidence for progressive accumulation of amino acid changes in the attachment protein | Q39869992 | ||
| Evolutionary pattern of human respiratory syncytial virus (subgroup A): cocirculating lineages and correlation of genetic and antigenic changes in the G glycoprotein | Q40041314 | ||
| Premature stop codons in the G glycoprotein of human respiratory syncytial viruses resistant to neutralization by monoclonal antibodies. | Q40065065 | ||
| Neutralization of respiratory syncytial virus by individual and mixtures of F and G protein monoclonal antibodies. | Q40130924 | ||
| Genetic variability of group A and B human respiratory syncytial viruses isolated from 3 provinces in China | Q40131159 | ||
| Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies | Q40181974 | ||
| Respiratory syncytial virus escape mutant derived in vitro resists palivizumab prophylaxis in cotton rats | Q40588255 | ||
| Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines | Q40779398 | ||
| Monoclonal antibody-resistant mutants selected with a respiratory syncytial virus-neutralizing human antibody fab fragment (Fab 19) define a unique epitope on the fusion (F) glycoprotein | Q40983230 | ||
| Frame shift mutations as a novel mechanism for the generation of neutralization resistant mutants of human respiratory syncytial virus. | Q41235315 | ||
| Antigenic structure, evolution and immunobiology of human respiratory syncytial virus attachment (G) protein | Q41625980 | ||
| Respiratory syncytial virus heterogeneity during an epidemic: analysis by limited nucleotide sequencing (SH gene) and restriction mapping (N gene). | Q41696677 | ||
| Subgroup prevalence and genotype circulation patterns of human respiratory syncytial virus in Belgium during ten successive epidemic seasons | Q41875782 | ||
| Loss of conserved cysteine residues in the attachment (G) glycoprotein of two human respiratory syncytial virus escape mutants that contain multiple A-G substitutions (hypermutations). | Q42673660 | ||
| Ten years of global evolution of the human respiratory syncytial virus BA genotype with a 60-nucleotide duplication in the G protein gene | Q42738026 | ||
| Genetic variability of group A human respiratory syncytial virus strains circulating in Germany from 1998 to 2007. | Q43117792 | ||
| Strain-specific serum antibody responses in infants undergoing primary infection with respiratory syncytial virus | Q43443712 | ||
| Effect of passive antibody on the immune response of cotton rats to purified F and G glycoproteins of respiratory syncytial virus (RSV). | Q43455771 | ||
| Comparison of strain-specific antibody responses during primary and secondary infections with respiratory syncytial virus | Q43520192 | ||
| The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness | Q43612954 | ||
| Prevalence and genetic characterization of respiratory syncytial virus (RSV) in hospitalized children in Korea | Q43984310 | ||
| Major changes in the G protein of human respiratory syncytial virus isolates introduced by a duplication of 60 nucleotides. | Q44422007 | ||
| Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants | Q44438075 | ||
| Involvement of the complement system in the protection of mice from challenge with respiratory syncytial virus Long strain following passive immunization with monoclonal antibody 18A2B2. | Q44541352 | ||
| An antigenic analysis of respiratory syncytial virus isolates by a plaque reduction neutralization test | Q44693028 | ||
| Selection and characterization of human respiratory syncytial virus escape mutants resistant to a polyclonal antiserum raised against the F protein | Q45359023 | ||
| P304 | page(s) | 59-82 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | Current Topics in Microbiology and Immunology | Q15752446 |
| P1476 | title | Influence of respiratory syncytial virus strain differences on pathogenesis and immunity | |
| P478 | volume | 372 |
| Q40267862 | Antigenic Drift Defines a New D4 Subgenotype of Measles Virus. |
| Q92360246 | Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B |
| Q64054630 | Emergence of new antigenic epitopes in the glycoproteins of human respiratory syncytial virus collected from a US surveillance study, 2015–17 |
| Q38952128 | Evidence of respiratory syncytial virus and parainfluenza-3 virus in Mexican sheep |
| Q104064738 | Evolution of respiratory syncytial virus genotype BA in Kilifi, Kenya, 15 years on |
| Q36438987 | Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection |
| Q33775484 | Infections Caused by HRSV A ON1 Are Predominant among Hospitalized Infants with Bronchiolitis in São Paulo City. |
| Q40059727 | Neutralizing epitopes of RSV and palivizumab resistance in Japan |
| Q40144736 | Preclinical Characterization of PC786, an Inhaled Small-Molecule Respiratory Syncytial Virus L Protein Polymerase Inhibitor |
| Q45326381 | Prefusion F, postfusion F, G antibodies and disease severity in infants and young children with acute respiratory syncytial virus infection |
| Q36353767 | Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera |
| Q41930150 | Prevalence and genetic characterisation of respiratory syncytial viruses circulating in Bulgaria during the 2014/15 and 2015/16 winter seasons. |
| Q36433969 | Respiratory Syncytial Virus Attachment Glycoprotein Contribution to Infection Depends on the Specific Fusion Protein. |
| Q36925097 | Respiratory Syncytial Virus whole-genome sequencing identifies convergent evolution of sequence duplication in the C-terminus of the G gene |
| Q40347024 | Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells |
| Q34785440 | Respiratory syncytial virus-associated mortality in hospitalized infants and young children. |
| Q49575441 | Seasonality and geographical spread of respiratory syncytial virus epidemics in 15 European countries, 2010 to 2016. |
| Q45324052 | Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein. |
| Q37536191 | Structural, antigenic and immunogenic features of respiratory syncytial virus glycoproteins relevant for vaccine development |
| Q45323691 | The Complexity of Antibody Responses Elicited against the Respiratory Syncytial Virus Glycoproteins in Hospitalized Children Younger than 2 Years |
| Q38750689 | Trivalency of a Nanobody Specific for the Human Respiratory Syncytial Virus Fusion Glycoprotein Drastically Enhances Virus Neutralization and Impacts Escape Mutant Selection |
| Q60046445 | Viral-Induced Enhanced Disease Illness |
Search more.